July 6, 2018

Please reload

Recent Posts

FDA Comments on Recently Released Rare Disease Guidance for Industry

September 16, 2015

Jonathan Goldsmith, M.D., F.A.C.P., FDA’s Associate Director, Rare Diseases Program, Center for Drug Evaluation and Research, comments on the recently...

1/2
Please reload

Featured Posts

Patagonia engages Torreya Capital

November 25, 2014

Torreya Capital, a division of the Financial West Investment Group, member FINRA/SIPC, is a leading corporate finance advisory boutique serving companies in the life sciences industry.  

Founded by Tim Opler and Mark Simon, Torreya has grown to have 20 professionals and a global presence in life sciences advisory.  Torreya has successfully completed more than a 100 assignments since they started in August 2007.  Torreya conducts business globally from two offices:  New York (Headquarters); and London.

 

Torreya is advising Patagonia in its efforts to raise capital and form strategic partnerships.  

 

Please reload

Patagonia Pharmaceuticals, LLC

50 Tice Blvd, Suite A26

Woodcliff Lake, NJ 07677

For more info: info@patagoniarx.com

© 2019 by Patagonia Pharmaceuticals, LLC